Schedule (route) |
Endpoint |
Vehicle |
Dose |
Treated/Control (%) |
Observations |
Q04DX003 (ip) |
mean tumor weight change |
saline |
2.5 mg/kg/injection |
13.0 |
Antitumor endpoint evaluated on day 16; 06/06 animals surviving on day 16 |
Q04DX003 (ip) |
mean tumor weight change |
saline |
5.0 mg/kg/injection |
67.0 |
Antitumor endpoint evaluated on day 16; 05/05 animals surviving on day 16 |
Q04DX003 (ip) |
mean tumor weight change |
saline |
10.0 mg/kg/injection |
-12.0 |
Antitumor endpoint evaluated on day 16; 04/06 animals surviving on day 16 |
Q04DX003 (ip) |
mean tumor weight change |
saline |
20.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 16; 00/06 animals surviving on day 16 |
Q04DX004 (ip) |
mean tumor weight change |
saline |
2.5 mg/kg/injection |
124.0 |
Antitumor endpoint evaluated on day 18; 06/06 animals surviving on day 18 |
Q04DX004 (ip) |
mean tumor weight change |
saline |
5.0 mg/kg/injection |
46.0 |
Antitumor endpoint evaluated on day 18; 06/06 animals surviving on day 18 |
Q04DX004 (ip) |
mean tumor weight change |
saline |
10.0 mg/kg/injection |
-29.0 |
Antitumor endpoint evaluated on day 18; 05/06 animals surviving on day 18 |
Q04DX004 (ip) |
mean tumor weight change |
saline |
20.0 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 18; 00/06 animals surviving on day 18 |